According to Megan Mullins, PhD, MPH, challenging cultural norms surrounding death and dying may reduce the receipt of low-value end-of-life cancer care.
Megan Mullins, PhD, MPH
Advertisement
Articles by Megan Mullins, PhD, MPH
Earlier and more frequent talks about disabling ICDs with patients receiving end-of-life care and their families may help avoid excessive pain.
Understanding patient preferences for intensive end-of-life treatment may better inform research assessing patients with terminal cancer diagnoses.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Neoadjuvant Pembrolizumab/Radiotherapy Earns EU Approval in HNSCC Group
2
What is the Impact of the SHARON Trial on Pancreatic Cancer Research?
3
Pembrolizumab/Belzutifan Improves DFS in ccRCC Following Nephrectomy
4
ZEN-3694 Earns FDA Orphan Drug Designation in NUT Carcinoma
5
